Symbol="REVB"
AssetType="Common Stock"
Name="Revelation Biosciences Inc"
Description="Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of immunological diagnostics and therapeutics for the prevention and treatment of disease. The company is headquartered in New York, New York."
CIK="1810560"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="REAL ESTATE & CONSTRUCTION"
Industry="BLANK CHECKS"
Address="5 WEST 21ST STREET, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="5033300"
EBITDA="-5873009"
PERatio="0.0145"
PEGRatio="None"
BookValue="2.118"
DividendPerShare="0"
DividendYield="0"
EPS="57.47"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.282"
ReturnOnEquityTTM="0.392"
RevenueTTM="0"
GrossProfitTTM="90905000"
DilutedEPSTTM="57.47"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="11.45"
TrailingPE="0.0145"
ForwardPE="7.79"
PriceToSalesRatioTTM="2.882"
PriceToBookRatio="0.891"
EVToRevenue="-"
EVToEBITDA="-"
Beta="0.308"
num_52WeekHigh="63.7"
num_52WeekLow="0.793"
num_50DayMovingAverage="1.054"
num_200DayMovingAverage="4.805"
SharesOutstanding="6048900"
DividendDate="None"
ExDividendDate="None"
symbol="REVB"
open="0.83"
high="0.86"
low="0.83"
price="0.84"
volume="114102.00"
latest_trading_day="2023-07-10"
previous_close="0.83"
change="0.01"
change_percent="0.7349%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="91"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="9"
Volume_recent_avg="554156"
Change_recent_avg="-0.01"
Delta_recent_avg="0.14"
Variance_recent_avg="0.07"
Change_ratio_recent_avg="-0.96"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_negative_10"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="9"
Aroon_momentum_negative="91"
image_negative_thumbnail_id_1="1160"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0194.jpeg"
image_negative_thumbnail_id_2="1121"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0154.jpeg"
image_neutral_thumbnail_id_1="521"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_neutral_thumbnail_id_2="563"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0036.jpeg"
image_positive_thumbnail_id_1="676"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0032.jpeg"
image_positive_thumbnail_id_2="654"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0054.jpeg"
image_professor_thumbnail_id_1="1196"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0030.jpeg"
image_professor_thumbnail_id_2="1203"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0037.jpeg"
